世界のウェスタンブロット法市場分析及び予測（～2018）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 REPORT DESCRIPTION 17
1.3 MARKETS COVERED 19
1.4 STAKEHOLDERS 20
1.5 RESEARCH METHODOLOGY 21
1.5.1 SECONDARY RESEARCH 22
1.5.2 PRIMARY RESEARCH 23
1.5.2.1 Key data from primary sources 24
1.5.3 MARKET SIZE ESTIMATION METHODOLOGY 24
1.5.4 MARKET FORECAST 27
1.5.5 MARKET DATA VALIDATION AND DATA TRIANGULATION 29
1.5.6 ASSUMPTIONS 30
2 EXECUTIVE SUMMARY 31
3 MARKET OVERVIEW 35
3.1 INTRODUCTION 36
3.2 MARKET DYNAMICS 36
3.2.1 MARKET DRIVERS 38
3.2.1.1 Global increase in R&D spending for life sciences likely to propel the western blotting market 38
3.2.1.2 Automated western blotting systems set to dictate the growth trajectory of western blotting instruments 38
3.2.1.3 Growing proteomics market likely to spur the western blotting market 39
3.2.1.4 Increasing prevalence of HIV likely to spur the western blotting market 40
3.2.1.5 Usage of western blotting for antibody validation likely to trigger its demand 40
3.2.2 MARKET RESTRAINTS 41
3.2.2.1 High cost of primary antibodies—A deterrent for the western blotting market 41
3.2.2.2 Emergence of alternative technologies likely to obscure the demand for western blotting 41
3.2.3 MARKET OPPORTUNITIES 42
3.2.3.1 Emerging Asian markets provide immense growth opportunities for the market 42
3.2.4 MARKET CHALLENGES 43
3.2.4.1 High level of care required for producing accurate results 43
3.3 MARKET SHARE ANALYSIS 44
3.3.1 WESTERN BLOTTING MARKET, BY KEY PLAYER 44
4 GLOBAL WESTERN BLOTTING MARKET, BY PRODUCT 50
4.1 INTRODUCTION 51
4.1.1 WESTERN BLOTTING INSTRUMENTS, BY TYPE 55
4.1.1.1 Manual Instruments 57
4.1.1.2 Semi-automated Instruments 58
4.1.1.3 Automated Instruments 60
4.1.2 WESTERN BLOTTING CONSUMABLES 61
4.1.2.1 Western Blotting Kits 64
4.1.2.2 Western Blotting Reagents 65
4.1.2.2.1 Chromogenic reagents 68
4.1.2.2.2 Chemiluminescent reagents 69
4.1.2.2.3 Fluorescent reagents 71
4.1.2.2.4 Chemifluorescent reagents 73
4.1.2.2.5 Radioisotopic reagents 74
4.1.2.3 Others 75
4.1.2.3.1 Western blotting membranes 76
4.1.2.3.2 Blotting papers 78
4.1.2.3.3 Molecular weight markers 78
5 GLOBAL WESTERN BLOTTING MARKET, BY APPLICATION 79
5.1 INTRODUCTION 80
5.1.1 DISEASE DIAGNOSIS 81
5.1.1.1 Human Immunodeficiency Virus (HIV) 84
5.1.1.2 Lyme Disease 86
5.1.1.3 Bovine Spongiform Encephalopathy (BSE) 87
5.1.1.4 Feline Immunodeficiency Virus (FIV) 88
5.1.1.5 Hepatitis B Virus (HBV) 89
5.1.1.6 Herpes Simplex Virus (HSV) 91
5.1.2 AGRICULTURE 92
5.1.3 BIOCHEMICAL & BIOMEDICAL RESEARCH 93
5.1.4 OTHER APPLICATIONS 94
6 GLOBAL WESTERN BLOTTING MARKET, BY END USER 96
6.1 INTRODUCTION 97
6.1.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 98
6.1.2 RESEARCH INSTITUTES 100
6.1.3 DIAGNOSTIC LABORATORIES 101
7 GLOBAL WESTERN BLOTTING MARKET, BY GEOGRAPHY 103
7.1 INTRODUCTION 104
7.2 NORTH AMERICA 109
7.2.1 INCREASE IN BIO-BASED DRUG RESEARCH TO PROPEL THE MARKET 110
7.2.2 RISE IN PRODUCTION OF GENETICALLY MODIFIED CROPS TRIGGERS THE MARKET IN NORTH AMERICA 112
7.2.3 GOVERNMENT FUNDING TO DRIVE THE MARKET IN NORTH AMERICA 113
7.2.4 RISE IN PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES IN THE U.S. TO DRIVE THE MARKET 115
7.2.5 INCREASING PREVALANCE OF HIV INFECTIONS TO PROPEL THE MARKET IN THE U.S. 115
7.3 EUROPE 116
7.3.1 INCREASE IN R&D INVESTMENTS TO BOOST THE MARKET IN EUROPE 117
7.3.2 INCREASE IN PRODUCTION OF GENETICALLY MODIFIED CROPS IN EUROPE LIKELY TO BOOST THE MARKET 119
7.3.3 ADVANCES IN BIOTECHNOLOGICAL & RESEARCH SECTORS IN MAJOR EUROPEAN REGIONS TO FUEL THE MARKET GROWTH 120
7.3.4 EUROPEAN COMMISSION FUNDS FOR LYME DISEASE TREATMENT LIKELY TO PROPEL THE MARKET 122
7.4 ASIA 123
7.4.1 LUCRATIVE PROTEOMICS MARKET IN INDIA & CHINA TO STIMULATE THE DEMAND FOR WESTERN BLOTTING INSTRUMENTS AND CONSUMABLES 124
7.4.2 RISING GOVERNMENT INTIATIVES FOR HIV DIAGNOSIS—A MAJOR PROPELLANT FOR THE MARKET IN ASIA 126
7.4.3 EXTENSIVE RESEARCH ON CROPS IN ASIA LIKELY TO BOOST THE WESTERN BLOTTING MARKET 128
7.4.4 GROWING PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES TO PROPEL THE MARKET IN INDIA & CHINA 129
7.5 REST OF THE WORLD (ROW) 130
7.5.1 FAVORABLE REGULATORY CHANGES TO INCREASE THE MARKET IN ISRAEL, NEW ZEALAND, AND AUSTRALIA 131
7.5.2 GROWING PROTEOMIC RESEARCH IN AUSTRALIA WILL DRIVE THE WESTERN BLOTTING MARKET 133
7.5.3 FEDERAL COLLABORATIONS IN AUSTRALIA TO BOLSTER THE DEMAND FOR WESTERN BLOTTING INSTRUMENTS AND CONSUMABLES 135
7.5.4 FLOURISHING BIOTECHNOLOGY AND PHARMACEUTICAL MARKETS IN BRAZIL TO PROPEL THE GROWTH OF THE MARKET 136
7.5.5 INCREASING FOCUS ON AFRICA BY PHARMACEUTICAL COMPANIES TO CREATE AVENUES FOR THE MARKET 136
7.5.6 HIGH PREVALENCE OF HIV COUPLED WITH FUNDING SUPPORT LIKELY TO PROVIDE IMPETUS TO THE SOUTH AFRICAN WESTERN BLOTTING MARKET 137
8 COMPETITIVE LANDSCAPE 138
8.1 INTRODUCTION 138
8.2 NEW PRODUCT LAUNCHES 140
8.3 EXPANSIONS 143
8.4 ACQUISITIONS 146
8.5 AGREEMENTS AND PARTNERSHIPS 148
8.6 OTHERS 150
9 COMPANY PROFILES 152
9.1 ADVANSTA INC. 152
9.2 ASSAY HORIZONS, INC. 156
9.3 BIO-RAD LABORATORIES, INC. 159
9.4 GE HEALTHCARE 165
9.5 LI-COR BIOSCIENCES 169
9.6 MERCK MILLIPORE 175
9.7 PERKINELMER, INC. 179
9.8 PROTEINSIMPLE, INC. 184
9.9 ROCHE APPLIED SCIENCE 188
9.10 SIGMA-ALDRICH CORPORATION 192
9.11 THERMO FISHER SCIENTIFIC, INC. 199

*Details on Business Overview, Company Snapshot, Product & Services, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.